期刊
CELL DEATH AND DIFFERENTIATION
卷 28, 期 5, 页码 1512-1531出版社
SPRINGERNATURE
DOI: 10.1038/s41418-020-00683-x
关键词
-
资金
- Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT [CCRC13GAL]
- Science Foundation Ireland [13/IA/1881, 16/US/3301]
- Health Research Board [13/IA/1881, 16/US/3301]
- Science Foundation Ireland (SFI) [13/IA/1881, 16/US/3301] Funding Source: Science Foundation Ireland (SFI)
BCL2 and BCL(X)L enhance the metabolic robustness of MCF7 breast cancer cells by increasing mitochondrial NAD(P)H and ATP levels, leading to improved resistance to nutrient deprivation and enhanced survival under metabolic stress.
The BCL2 family of proteins regulate apoptosis by controlling mitochondrial outer membrane permeability. However, the effects on mitochondrial structure and bioenergetics have also been reported. Here we comprehensively characterized the effects of BCL2 and BCL(X)L on cellular energetics in MCF7 breast cancer cells using time-lapse confocal single-cell imaging and mitochondrial and cytosolic FRET reporters. We found that BCL2 and BCL(X)L increase the metabolic robustness of MCF7 cells, and that this was associated with increased mitochondrial NAD(P)H and ATP levels. Experiments with the F1F0 synthase inhibitor oligomycin demonstrated that BCL2 and in particular BCL(X)L, while not affecting ATP synthase activity, more efficiently coupled the mitochondrial proton motive force with ATP production. This metabolic advantage was associated with an increased resistance to nutrient deprivation and enhanced clonogenic survival in response to metabolic stress, in the absence of profound effects on cell death. Our data suggest that a primary function of BCL(X)L and BCL2 overexpression in tumor cells is to increase their resistance to metabolic stress in the tumor microenvironment, independent of cell death signaling.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据